Searched for
DR REDDY EARNINGS
Nifty in control of FIIs? The unlucky 13 bluechips facing the hardest institutional selloffForeign investors have significantly reduced holdings in many Nifty companies since September 2024. This has impacted top blue-chip stocks,...12 Jun, 2026, 10.05 AM IST- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...11 Jun, 2026, 10.31 AM IST
- SBI Chairman, Apple India MD among 29 members appointed to Board of TradeThe government has appointed 29 non-official members to the Board of Trade. This includes prominent figures like SBI Chairman CS Setty and ...02 Jun, 2026, 09.06 PM IST
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...02 Jun, 2026, 05.48 AM IST
- Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...01 Jun, 2026, 01.12 PM IST
- Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap playsIndian equity markets show a mixed but improving consumption trend, with selective FMCG and premium retail outperforming. Page Industries i...22 May, 2026, 11.59 AM IST
- Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj PandeyGlobal markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...20 May, 2026, 12.06 PM IST
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...20 May, 2026, 12.05 PM IST
- Dr Reddy's shares in focus after Q4 net profit tumbles 86% YoY; Morgan Stanley, Goldman Sachs weigh inDr. Reddy's Laboratories shares: The pharma major posted a sharp 86% YoY drop in Q4FY26 consolidated net profit to Rs 221 crore, compared w...13 May, 2026, 09.13 AM IST
- Dr Reddy's Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announcedDr Reddy's Laboratories Q4 Results: Dr. Reddy's Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter ...12 May, 2026, 05.08 PM IST
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...10 May, 2026, 09.39 AM IST
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets ended higher driven by positive election trends, with gains in financials, pharma, and metals. Nifty held above key support ...04 May, 2026, 08.59 PM IST
- Rupee at 95, crude at $120+: Why India's markets are flying blind into a stormMarket expert Sudip Bandyopadhyay warns Indian markets face significant risks. High oil prices and a potential monsoon deficit are major co...01 May, 2026, 09.49 AM IST
- Dr Reddy’s shares fall 2% after Goldman Sachs downgrades, Citi turns cautiousDr Reddy’s shares fell after Goldman Sachs and Citigroup turned cautious, citing limited growth visibility, pipeline concerns and valuation...24 Apr, 2026, 10.35 AM IST
- Buy, Sell or Hold: Motilal Oswal maintains buy on UTI AMC; Goldman Sachs downgrades Dr Reddy’s LaboratoriesBrokerages remain selective, with Motilal Oswal maintaining a bullish stance on UTI AMC and Aditya Birla Sun Life AMC, citing steady AUM gr...24 Apr, 2026, 09.56 AM IST
- Dr Reddy’s Q4 Results: Consolidated PAT slumps 28%, misses estimates; co to pay Rs 25 dividendThe company’s board, however, approved a final dividend of Rs 25 per share for the financial year 2020-21.14 May, 2021, 08.00 PM IST
- Dr Reddy’s Q3 results: Net profit at Rs 19.8 crore, sharply lower than Street estimatesThe company’s consolidated revenues grew 12 per cent on year to Rs. 4,930 crore, which was largely in-line with analysts’ estimate of Rs. 4...29 Jan, 2021, 11.57 AM IST
Load More
